IL-1调节破骨细胞生成的新奇机制

2012-04-10 唐宾泽 生物谷

       IL-1是一个炎症有关的细胞因子。在各种病理条件下,IL-1被发现与骨质疏松有关。研究表明,其促进了破骨细胞的形成、生长以及功能发挥。最近,美国阿拉巴马大学Suzanne M. Michalek等人发现,单独的IL-1就可以有效的延长破骨细胞的生存,同时激活破骨细胞的功能,而且IL-1调节破骨细胞生成需要NF-&k

       IL-1是一个炎症有关的细胞因子。在各种病理条件下,IL-1被发现与骨质疏松有关。研究表明,其促进了破骨细胞的形成、生长以及功能发挥。最近,美国阿拉巴马大学Suzanne M. Michalek等人发现,单独的IL-1就可以有效的延长破骨细胞的生存,同时激活破骨细胞的功能,而且IL-1调节破骨细胞生成需要NF-κB的受体活化剂的帮助。相关论文发表在3月13日的美国《生化周刊》(JBC)上。

       一直以来,依赖RANKL的IL-1调节破骨细胞生成的分子基础还未可知。本次研究表明:虽然IL-1不能激活破骨细胞基因编码的基质金属蛋白酶9(MMP9),组织酶K(Ctsk),抗酒石酸磷酸酶(Car2)在骨髓巨噬细胞(BMMs)中的表达,RANKL可以致使这些破骨细胞基因应答于IL-1。

       实验进一步证明,单独的IL-1不能够引起NFATc1(一中对破骨细胞生成的主导性转录调节因子)的表达,但是,如果有一定水平的RANKL或者RANKL预处理物的话,IL-1在BMMs中可以上调NFATc1的表达。

       最后,本次实验发现,一种已知的,在IL-1RI 信号通路中的关键部件--MyD88,通过其上调破骨细胞标记以及NFATc1基因的表达,在IL-1调节的破骨细胞生成中起着至关重要的作用。

       这项研究发现了IL-1调节破骨细胞生成的新奇机制,支持了IVVY模体作为治疗炎症骨骼流失的最具治疗潜力的位点这一观点。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1309971, encodeId=3e6f13099e1dd, content=<a href='/topic/show?id=2830e349460' target=_blank style='color:#2F92EE;'>#破骨细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73494, encryptionId=2830e349460, topicName=破骨细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e30378, createdName=caobinglei8079, createdTime=Thu Apr 12 14:37:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495001, encodeId=b7fc14950017f, content=<a href='/topic/show?id=3c0b10182102' target=_blank style='color:#2F92EE;'>#骨细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101821, encryptionId=3c0b10182102, topicName=骨细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=723c9147696, createdName=jj000004, createdTime=Thu Apr 12 14:37:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508155, encodeId=a0bd15081552c, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9624, encryptionId=8d4596248e, topicName=IL-1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6cf9946833, createdName=jjjiang0202, createdTime=Thu Apr 12 14:37:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1309971, encodeId=3e6f13099e1dd, content=<a href='/topic/show?id=2830e349460' target=_blank style='color:#2F92EE;'>#破骨细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73494, encryptionId=2830e349460, topicName=破骨细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e30378, createdName=caobinglei8079, createdTime=Thu Apr 12 14:37:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495001, encodeId=b7fc14950017f, content=<a href='/topic/show?id=3c0b10182102' target=_blank style='color:#2F92EE;'>#骨细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101821, encryptionId=3c0b10182102, topicName=骨细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=723c9147696, createdName=jj000004, createdTime=Thu Apr 12 14:37:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508155, encodeId=a0bd15081552c, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9624, encryptionId=8d4596248e, topicName=IL-1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6cf9946833, createdName=jjjiang0202, createdTime=Thu Apr 12 14:37:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1309971, encodeId=3e6f13099e1dd, content=<a href='/topic/show?id=2830e349460' target=_blank style='color:#2F92EE;'>#破骨细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73494, encryptionId=2830e349460, topicName=破骨细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e30378, createdName=caobinglei8079, createdTime=Thu Apr 12 14:37:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495001, encodeId=b7fc14950017f, content=<a href='/topic/show?id=3c0b10182102' target=_blank style='color:#2F92EE;'>#骨细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101821, encryptionId=3c0b10182102, topicName=骨细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=723c9147696, createdName=jj000004, createdTime=Thu Apr 12 14:37:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508155, encodeId=a0bd15081552c, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9624, encryptionId=8d4596248e, topicName=IL-1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6cf9946833, createdName=jjjiang0202, createdTime=Thu Apr 12 14:37:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
    2012-04-12 jjjiang0202